Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2008
10/02/2008US20080241852 Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
10/02/2008US20080241851 Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008US20080241850 Based on degree of coloring in liquid sample mixed with indicator; xanthene dyes; immunoassay; for detecting creatine concentrations
10/02/2008US20080241847 Biological surveillance probe for recovering tumor cells; biosensor for collection of bioparticles
10/02/2008US20080241846 Using presence of single nucleotide polymorphism in kinesin-like protein 6 (KIF6) gene as evaluative tool in diagnosing coronary heart disease and aneurysm
10/02/2008US20080241840 Using tau protein specific immunoglobulin/single-stranded DNA fusion as evaluative tool in diagnosis alzheimer's disease
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241834 Using germline abnormalities in breast cancer gene as prognostic tool in determining efficacy of taxane-derived cytostatics in treatment of breast cancer
10/02/2008US20080241827 Methods For Detecting A Mutant Nucleic Acid
10/02/2008US20080241826 Probe And Primer For Tubercle Bacillus Detection, And Method Of Detecting Human Tubercle Bacillus Therewith
10/02/2008US20080241825 Materials and Methods for Treatment of Cancer
10/02/2008US20080241821 Assay for porcine circovirus production
10/02/2008US20080241820 Fluorescence activated cell sorting; kits
10/02/2008US20080241816 Leuco dye selected from triphenylmethane leuco dye (such as N,N,N',N',N'',N''-hexa-3-sulfopropyl-4-4',4"-triaminotriphenylmethane), phenothiazine leuco dye, and diphenylamine leuco dye
10/02/2008US20080241375 Method for preparing surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
10/02/2008US20080241321 Method and Device For Sorting and Packaging of Foods
10/02/2008US20080241259 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof
10/02/2008US20080241207 Culture medium; antibodies; bioassays; drug screening; administering with an agonist or antagonist; stromal cells; implants
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241186 Nucleic acid vaccines for prevention of flavivirus infection
10/02/2008US20080241182 Mycobacterial polypeptide for use in producing vaccine to prevent grampositive bacterial infection
10/02/2008US20080241179 Structural proteins of fish pancreatic disease virus and uses thereof
10/02/2008US20080241178 Novel human gene functionally related to dyslexia
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241171 Stem Cell Populations and Methods of Use
10/02/2008US20080241169 Using phage displayed prion specific immunoglobulin to prevent aggregation of amyloid plaques; treating alzheimer's disease
10/02/2008US20080241168 Transmembrane protein amigo and uses thereof
10/02/2008US20080241167 Inhibiting membrane fusion between human immunodeficiency virus and chemokine receptor-5 expressing cells using receptor specific immunoglobulins
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241162 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241154 Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family
10/02/2008US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241151 Neisserial peptides for use in developing vaccine for prevention and treatment of menigococcal septicemia and meningitis
10/02/2008US20080241150 Peptide comprising Lin12-Notch repeats (LNR) for use in identifying and designing modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241149 Antibodies to complementary peptides of thrombin or portions thereof
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241142 Neuropilin/VEGF-C/VEGFR-3 Materials and Methods
10/02/2008US20080241137 Cancerous disease modifying antibodies
10/02/2008US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders
10/02/2008US20080241133 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
10/02/2008US20080241131 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
10/02/2008US20080241130 Methods and compositions for modulating il-17f/il-17a biological activity
10/02/2008US20080241129 Adipocyte secreted protein ccdc80 is a potent stimulator of bone formation
10/02/2008US20080241126 Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM
10/02/2008US20080241125 Muc1-ikb kinase complexes and their activities
10/02/2008US20080241114 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/02/2008US20080241108 Bone Morphogenic Protein Binding Peptide
10/02/2008US20080241106 Using nervous system protein to induce stem cell differentiation into pancreatic tissues; tissue engineering and repair; regenerative medicine;
10/02/2008US20080241104 Espfu nucleic acids and proteins and uses thereof
10/02/2008US20080241097 Methods of treating neurological conditions with hematopoeitic growth factors
10/02/2008US20080241066 Anti-PRL-3 antibodies and methods of use thereof
10/02/2008US20080241064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/02/2008US20080241062 Cancerous disease modifying antibodies
10/02/2008US20080240990 Adaptor for sample vial
10/02/2008US20080240539 Method For Imaging And Differential Analysis Of Cells
10/02/2008US20080238445 Measuring Device For Measuring the State of Oils or Fats
10/02/2008US20080237130 Low cost liquid chromatography simple compound chiral mobile phase; separating larger classes of enantiomers; easier method development; expands column choices; including nonchiral reverse phase
10/02/2008US20080237061 Electronic methods for the detection of analytes
10/02/2008US20080237039 Extracellular potential sensing element, device for measuring extracellular potential, apparatus for measuring extracellular potential and method of measuring extracellular potential by using the same
10/02/2008US20080236770 Reacting free fatty acids in wood fiber suspension with oxygen to form enoyl-coenzymes A and hydrogen peroxide; reacted peroxide with a dye precursor to produce electrochemical species and measurable color change; determining the concentration by spectrometry or chromatography
10/02/2008US20080236249 Method for identification of persons based on the analysis of volatile substances
10/02/2008US20080236246 Gas sensor housing for use in high temperature gas environments
10/02/2008US20080236245 Contaminant scanning system
10/02/2008DE112006001097T5 System für die funktionelle Analyse von Polypeptiden und Analyseverfahren für Polypeptide System for functional analysis of polypeptides and analysis methods for polypeptides
10/02/2008DE102007043669A1 Fractional oxygen saturation measuring method, involves implementing procedural correction method, which enables display of all saturation parameters such as fractional, functional and dysfunctional hemoglobin saturation
10/02/2008DE102007017360A1 Device for determination of barrier effect to examine textile laminar formation against fluid carried particles, has textile laminar formation, which is stressed with combination of hydrostatic, mechanical and friction forces
10/02/2008DE102007015667A1 Verfahren zur Ermittlung des Vernetzungsgrades von Polymererzeugnissen Method for determining the degree of crosslinking of polymer products
10/02/2008DE102007015100A1 Behälter für mehrere Teststreifen Container for a plurality of test strips
10/02/2008DE102007004339B4 Verfahren und Vorrichtung zur Bestimmung des Phosphorgehaltes einer wässrigen Probe Method and apparatus for determining the phosphorus content of an aqueous sample
10/02/2008DE10101430B4 Lösliche cyclische Analoga zur Modulation der Amyloidogenese Soluble cyclic analogues in the modulation of amyloidogenesis
10/02/2008CA2719522A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
10/02/2008CA2682661A1 Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity
10/02/2008CA2682543A1 Immunoassays and characterization of biomolecular interactions using self- assembled monolayers
10/02/2008CA2682503A1 Cartilage intermediate layer protein 2 c1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008CA2682260A1 Method for measuring dna methylation
10/02/2008CA2682030A1 Methods and agents for evaluating inflammatory bowel disease, and targets for treatment
10/02/2008CA2681958A1 Measuring air quality using a micro-optical mechanical gas sensor
10/02/2008CA2681899A1 Method, array and use thereof
10/02/2008CA2681792A1 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
10/02/2008CA2681766A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008CA2681577A1 Apex as a marker for lung cancer
10/02/2008CA2681412A1 Analyte sensor
10/02/2008CA2681393A1 New imidazolo-heteroaryl derivatives and biological applications thereof
10/02/2008CA2681190A1 Functional identification of proteins underlying icrac activity in a cell
10/02/2008CA2681144A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008CA2681051A1 Assays and methods for determining stim2 activity
10/02/2008CA2680832A1 Method for detecting autoprocessed, secreted pcsk9
10/02/2008CA2680781A1 A device for measuring an electrical parameter in milk and a milking apparatus including such a device
10/02/2008CA2680237A1 Constructs and libraries comprising antibody surrogate light chain sequences
10/02/2008CA2680102A1 Systems and methods for detection of an airborne contaminant
10/02/2008CA2680046A1 Methods of diagnosing, classifying and treating endometrial cancer and precancer
10/02/2008CA2679573A1 Improved antibody profiling sensitivity through increased reporter antibody layering
10/02/2008CA2653967A1 Lyase enzymes, nucleic acids encoding them and methods for making and using them
10/01/2008EP1975628A1 Analytical instrument
10/01/2008EP1975625A2 Sample analyzer, sample analyzing method, and computer program product
10/01/2008EP1975622A1 Reagent for measuring clotting time and method for stabilizing tissue factor
10/01/2008EP1975621A1 Method for determination of oxidative stress
10/01/2008EP1975620A2 Three hybrid assay system
1 ... 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 ... 3937